Showing results (41-50 of 51) with videos related to
Sort By:
Pageof 6
Journal of Clinical Neurology (Seoul, Korea)|July 5, 2018
Clinical Heterogeneity of Anti-GM2-Ganglioside-Antibody SyndromeJong Kuk Kim, Yoo Hwan Kim, Byeol A Yoon, et al.Diagnostics (Basel, Switzerland)|August 27, 2021
Serum Peptide Immunoglobulin G Autoantibody Response in Patients with Different Central Nervous System Inflammatory Demyelinating DisordersHye Lim Lee, Jin-Woo Park, Jin Myoung Seok, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|November 5, 2019
Serum FAM19A5 in neuromyelitis optica spectrum disorders: Can it be a new biomarker representing clinical status?Hye Lim Lee, Hung Youl Seok, Han-Wook Ryu, et al.Journal of Clinical Neurology (Seoul, Korea)|January 8, 2025
Profiling of Anti-Signal-Recognition Particle Antibodies and Clinical Characteristics in South Korean Patients With Immune-Mediated Necrotizing MyopathySoo-Hyun Kim, Yunjung Choi, Eun Kyoung Oh, et al.Journal of the Neurological Sciences|July 19, 2017
A multicenter prospective observational study on the safety and efficacy of tacrolimus in patients with myasthenia gravisSuk-Won Ahn, In Soo Joo, Byung-Jo Kim, et al.Journal of the Neurological Sciences|September 7, 2024
Potential prognostic value of rheumatoid factor in anti-aquaporin 4-immunoglobin G-positive neuromyelitis optica spectrum disordersHye Lim Lee, Jin Myoung Seok, Soon-Young Hwang, et al.Journal of Korean Medical Science|May 14, 2024
Impact of COVID-19 Infection and Its Association With Previous Vaccination in Patients With Myasthenia Gravis in Korea: A Multicenter Retrospective StudyHee Jo Han, Seung Woo Kim, Hyunjin Kim, et al.Journal of Neurology|November 17, 2022
Clinical pitfalls and serological diagnostics of MuSK myasthenia gravisYoung Nam Kwon, Mark Woodhall, Jung-Joon Sung, et al.Journal of Clinical Neurology (Seoul, Korea)|March 11, 2025
Evaluating Rituximab Failure Rates in Neuromyelitis Optica Spectrum Disorder: A Nationwide Real-World Study From South KoreaSu-Hyun Kim, Ju-Hong Min, Sung-Min Kim, et al.JAMA Network Open|February 13, 2026
Disability and Relapse Risk in Late-Onset Myelin Oligodendrocyte Glycoprotein Antibody-Associated DiseaseHyunjin Ju, Ki Hoon Kim, Sook Young Woo, et al.Pageof 6